Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Aptose Biosciences stock
Learn how to easily invest in Aptose Biosciences stock.
Aptose Biosciences Inc is a biotechnology business based in the US. Aptose Biosciences shares (APTO) are listed on the NASDAQ and all prices are listed in US Dollars. Aptose Biosciences employs 41 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Aptose Biosciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – APTO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Aptose Biosciences stock price (NASDAQ: APTO)Use our graph to track the performance of APTO stocks over time.
Aptose Biosciences shares at a glance
|Latest market close||$0.58|
|52-week range||$0.58 - $2.78|
|50-day moving average||$0.77|
|200-day moving average||$1.07|
|Wall St. target price||$8.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.67|
Buy Aptose Biosciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Aptose Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aptose Biosciences price performance over time
|1 week (2022-09-23)||-3.84%|
|1 month (2022-09-01)||-26.08%|
|3 months (2022-07-01)||-28.34%|
|6 months (2022-03-31)||-57.61%|
|1 year (2021-10-01)||-75.57%|
|2 years (2020-10-01)||-90.76%|
|3 years (2019-10-01)||1.92|
|5 years (2017-09-29)||1.48|
Aptose Biosciences financials
|Gross profit TTM||$0|
|Return on assets TTM||-42.31%|
|Return on equity TTM||-75.1%|
|Market capitalisation||$54.8 million|
TTM: trailing 12 months
Aptose Biosciences share dividends
We're not expecting Aptose Biosciences to pay a dividend over the next 12 months.
Have Aptose Biosciences's shares ever split?
Aptose Biosciences's shares were split on a 1:12 basis on 5 October 2014. So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aptose Biosciences shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Aptose Biosciences shares which in turn could have impacted Aptose Biosciences's share price.
Aptose Biosciences share price volatility
Over the last 12 months, Aptose Biosciences's shares have ranged in value from as little as $0.58 up to $2.78. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aptose Biosciences's is 1.3943. This would suggest that Aptose Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Aptose Biosciences overview
Aptose Biosciences Inc. , a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops luxeptinib, which is in Phase 1a/b clinical trial for treating patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic leukemia, small lymphocytic lymphoma, and various non-Hodgkin's lymphomas, as well as AML and HR MDS; and APL-581, a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program. It has agreements with CrystalGenomics, Inc. and OHM Oncology. The company was formerly known as Lorus Therapeutics Inc.
Aptose Biosciences in the news
Sanofi's (SNY) Dupixent Gets FDA Nod for Prurigo Nodularis
Merck's (MRK) Keytruda Gets Four New Approvals in Japan
Seagen (SGEN) Inks Deal With LAVA Therapeutics for LAVA-1223
Frequently asked questionsWhat percentage of Aptose Biosciences is owned by insiders or institutions?
Currently 5.372% of Aptose Biosciences shares are held by insiders and 27.27% by institutions. How many people work for Aptose Biosciences?
Latest data suggests 41 work at Aptose Biosciences. When does the fiscal year end for Aptose Biosciences?
Aptose Biosciences's fiscal year ends in December. Where is Aptose Biosciences based?
Aptose Biosciences's address is: 251 Consumers Road, Toronto, ON, Canada, M2J 4R3 What is Aptose Biosciences's ISIN number?
Aptose Biosciences's international securities identification number is: CA03835T2002 What is Aptose Biosciences's CUSIP number?
Aptose Biosciences's Committee on Uniform Securities Identification Procedures number is: 03835T101
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert